Latest Ipsen News & Updates

See the latest news and media coverage for Ipsen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Ipsen

Global specialty biopharmaceutical company

ipsen.com

Headquarters: Paris, France
Company type: Public company
Number of employees: 6,500–10,000
Industry: Pharmaceuticals

Last updated Today

Latest news about Ipsen

In short: Ipsen achieved record H1 2026 sales growth, upgraded its guidance, and completed the acquisitions of Kartos and Memo Therapeutics.

Company announcements

August 21 Ipsen

Ipsen completes acquisition of Kartos Therapeutics

This strengthens the late-stage Oncology pipeline with navtemadlin for myelofibrosis treatment.

July 30 Ipsen

Ipsen delivers excellent H1 2026 results and upgrades guidance

Sales grew 23.5% at CER, core operating margin reached 38.6%, and full-year guidance was raised.

July 29 Ipsen

Ipsen nominates Catherine Bradley as independent Director

She succeeds Ms. Witts, effective immediately, bringing over 30 years of experience in investment banking and corporate governance.

July 24 Ipsen

Ipsen announces BOLD trial missed primary endpoint

The Phase III trial for biliary atresia did not improve native liver survival versus placebo.

Media coverage

September 11 GuruFocus

ABBV Looks 15.8% Overvalued on GF Value™ as Dividend Sustainabil

On September 11, 2026, Ipsen announced plans to explore building a manufacturing facility in the...

August 21 Les Echos

Ipsen has completed the acquisition of US biotech Kartos Therapeutics

PARIS (Agefi-Dow Jones)--Pharmaceutical laboratory Ipsen announced on Friday that it had completed the acquisition of American biopharmaceutical company Kartos Therapeutics, specializing in hemato-oncolog...

August 20 Yahoo Finance

Regeneron to challenge Ipsen as FDA clears bone disease drug

Pasatru’s approval sets up a market battle in a rare indication where the only available treatment h...

August 13 Boursier.com

Ipsen rises

(Boursier.com) — A profitable day for Ipsen shares on the Paris Stock Exchange. The stock indeed gained 1.29% of its value, closing the session...

Never miss news about Ipsen

Track Ipsen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Ipsen competitors & trending companies

Browse news for competitors to Ipsen and other trending companies.